Dalton Transactions Dynamic Article Links Cite this: Dalton Trans., 2011, 40, 9145 www.rsc.org/dalton PAPER C-Branched chiral (racemic) macrocyclic amino acids: structure of their Ni(II), Zn(II) and Cu(II) complexes† Daniel Pellico,a Mar Gómez-Gallego,*a Rosa Escudero,a Pedro Ramı́rez-López,b Montserrat Olivánc and Miguel A. Sierra*a Received 30th March 2011, Accepted 9th June 2011 DOI: 10.1039/c1dt10539f A new procedure for the synthesis of macrocyclic embedded bis-a-amino acids and their use as cation-ligands is described. These compounds are able to form stable Cu(II), Zn(II) and Ni(II) complexes as long as they have a flexible tether between the two nitrogen atoms. For a given macrocycle, the X-ray diffraction studies revealed diastereomerically pure complexes having different geometries depending on the metal ion. Introduction Polyazamacrocycles and macrocycles containing mixed donor atoms (i.e. N, O) 1 are well known for their ability to bind metal ions.1,2 To broaden their chelating abilities and thence the scope of their applications, these structures frequently incorporate functionalized pendant arms linked to the nitrogen atoms (Fig. 1), generally carboxylic acids or their derivatives3 (2–4), amines,4 and more rarely phosphonic5 and sulfonyl groups.6 These structural modifications modulate the selectivity of a given chelating cavity from first-row transition divalent metal ions to the lanthanides.7 The versatility of these structures as metal binding agents has been exploited in different fields ranging from antitumor agents,8 biomedical applications (among others, contrast agents and shift reagents in magnetic resonance imaging (MRI) based techniques)9 to luminescent sensors in optical methods.7h–l,10 By contrast, the analogous C-branched polyazamacrocyclic cavities have been hardly studied. The few structures reported are generally azacyclophanes such as 5–7,11 analogous to con- formationally constrained a-amino acids and of great interest as synthetic receptors to probe the binding mode of bioactive molecules (Fig. 2).12 However, the use of these chiral cavities to complex metal ions has not been reported. The search for new small molecule chelating agents is an interesting area of research, as they constitute one of the future aDepartamento de Quı́mica Orgánica, Facultad de Quı́mica, Universi- dad Complutense, 28040, Madrid, Spain. E-mail: margg@quim.ucm.es, sierraor@quim.ucm.es bInstituto de Quı́mica Orgánica, Consejo Superior de Investigaciones Cientı́ficas (CSIC), Juan de la Cierva 3, 28006, Madrid, Spain cDepartamento de Quı́mica Inorgánica, Instituto de Sı́ntesis Quı́mica y Catálisis Homogénea, Universidad de Zaragoza-CSIC, 50009, Zaragoza, Spain † Electronic supplementary information (ESI) available: 1H and 13C-NMR spectra of new compounds 11–16. Crystallographic Information Files (CIF) for compounds 8a-Ni(II), 8a-Zn(II), and 8a-Cu(II). CCDC reference numbers 819737–819739. For ESI and crystallographic data in CIF or other electronic format, see DOI: 10.1039/c1dt10539f Fig. 1 promising strategies for treating diseases associated with localized metal accumulation.13 Metals such as iron, copper, and zinc play complicated roles in human health and disease. While all three metals are essential nutrients utilized as various protein cofactors, their misappropriation within cells and tissues can lead to significant damage that has been linked to Parkinson’s, Alzheimer’s, and other neurodegenerative diseases.13,14 Our ongoing work devoted to preparing different macro- cyclic structures having specific properties15 by peripheral functionalization16 of preformed macrocyclic di- and polyimines, led us to devise the synthesis of a series of novel chiral macrocycles 8 (Fig. 2) which are constrained bis-a-aminoacids17 having the structural features to bind metal ions (that is, a framework with mixed N,O donor atoms) and C-linked carboxylate groups as branched arms.18 In this work we also study their ability to form This journal is © The Royal Society of Chemistry 2011 Dalton Trans., 2011, 40, 9145–9153 | 9145 D ow nl oa de d by In sti tu to d e M ic ro bi ol og ía B io qu ím ic a on 0 5 Se pt em be r 2 01 1 Pu bl ish ed o n 08 A ug us t 2 01 1 on h ttp :// pu bs .rs c. or g | d oi :1 0. 10 39 /C 1D T1 05 39 F View Online http://dx.doi.org/10.1039/c1dt10539f http://dx.doi.org/10.1039/c1dt10539f http://dx.doi.org/10.1039/c1dt10539f Fig. 2 complexes with Ni(II), Zn(II) and Cu(II), and discuss their X-ray structures. Results and discussion The synthesis of the bis-a-aminoacids 8 was carried out starting from the corresponding macrocyclic diimines 9–12 as shown in Scheme 1. Thus, diimines 9–12 were transformed into the corre- sponding bis-aminonitriles 13–16 by a double Strecker reaction,19 at room temperature using trimethylsilyl cyanide (TMSCN) as the cyanide source. Compounds 13–16 were obtained in quantitative yields directly from the reaction crude, and as diastereomeric mixtures. In all cases their IR spectra showed weak CN stretch- ing bands in the range 2227–2230 cm-1, characteristic of a- aminonitriles.20 Compounds 13–16 are slightly unstable and were used in the next step without further purification (see experimental section for details).21 The assignment of the stereochemistry of the meso and racemic isomers in each case, was carried out by the study of the CH signals in the 1H-NMR spectra in the presence of Eu(III) tris[3-(heptafluoropropylhydroxymethylene)- (+)-camphorate] Eu(hfc)3. After the addition of this chiral shift reagent, the splitting of the CH singlets at 4.84, 4.83, 5.20 and 4.91 ppm (compounds 13–16, respectively) was clearly observed, in concordance with the expected behavior for RR/SS (racemic) isomers. However, in all cases, the CH signals at 5.02, 5.01, 5.33 and 4.98 ppm (compounds 13–16, respectively), remained unaltered as expected for the RS/SR (meso) form. The addition of the lanthanide hardly affects the rest of the signals in the NMR spectra, which points to the coordination of the Eu(III) with the carboxylate groups outside the macrocycle.7b Bis-aminonitriles 13–16 were hydrolyzed by refluxing in HCl to the corresponding bis-a-aminoacids 8a–d which were ob- tained as diastereomeric mixtures of hydrochlorides, with yields ranging from 61–73% (Scheme 1). The stereochemistry of the meso/racemic isomers of compounds 8a–d was again established by means of 1H-NMR experiments in the presence of Eu(hfc)3. In all cases, the meso/racemic isomeric ratios were identical to those of the previous aminonitriles, indicating that there was no epimerization of the stereogenic centers during the acid treatment. As an example, Fig. 3 shows the Eu(hfc)3 1H-NMR experiment with bis-a-aminoacid 8a. The addition of the chiral shift reagent provoked the shielding of both CH signals but only the splitting of the more deshielded CH singlet (racemic isomer). The ability of the macrocyclic bis-a-aminoacids 8a–d to form complexes with divalent metal cations was next addressed. The complexes were formed by treating solutions of equimolar amounts of the corresponding bis-aminoacid with Ni(II), Zn(II) and Cu(II) salts, at pH 8 at room temperature. Bis-a-aminoacids 8a and 8b having flexible tethers between the amino groups, were able to form stable complexes with all the divalent metals Scheme 1 9146 | Dalton Trans., 2011, 40, 9145–9153 This journal is © The Royal Society of Chemistry 2011 D ow nl oa de d by In sti tu to d e M ic ro bi ol og ía B io qu ím ic a on 0 5 Se pt em be r 2 01 1 Pu bl ish ed o n 08 A ug us t 2 01 1 on h ttp :// pu bs .rs c. or g | d oi :1 0. 10 39 /C 1D T1 05 39 F View Online http://dx.doi.org/10.1039/c1dt10539f Fig. 3 (A) 1H-NMR (D2O, 295 K) spectrum (CH signals) of 8a. (B) 1H-NMR (D2O, 295 K) spectrum (CH signals) of 8a after the addition of Eu(hfc)3. tested, whereas bis-a-aminoacids 8c and 8d bearing rigid tethers, failed. The characterization of the metal complexes was made by ESI-MS spectra (positive mode) which showed in all cases the corresponding [M+Na]+ and [M+H]+ peaks with the expected isotopic distribution (see for example Fig. 4). Further information about the structure of the metal complexes formed was gained by X-ray diffraction analysis. Suitable crystals were obtained by slow crystallization at room temperature from solutions of complexes 8a-Ni(II) (MeOH/CH3CN/H2O), 8a- Zn(II) (MeOH/H2O) and 8a-Cu(II) (MeOH/H2O). In each case only crystals of a pure diastereomeric complex were obtained and the analysis of their structures revealed different coordination modes, depending on the nature of the metal. Thus, for 8a-Ni(II) the crystals correspond to the racemic complex and the metal complex is a distorted octahedron involving the nitrogen atoms of the macrocyclic ring, the oxygen atoms of the carboxylates and the oxygen atoms of the ether groups (Fig. 5). Bond distances fall in the range 2.02–2.13 Å, typical for Ni(II) in an octahedral environment. An extended view of the structure of 8a-Ni(II) (Fig. 6) shows that the molecules of this complex are associated by means of intermolecular hydrogen bonds between the hydrogen atoms of the NH groups and the nickel-bonded oxygen atoms of the Fig. 5 Molecular diagram of complex 8a-Ni(II). Selected bond lengths (Å) and angles (deg): Ni–O(1) = 2.0311(17), Ni–O(3) = 2.0376(17), Ni–O(5) = 2.1339(18), Ni–O(6) = 2.1356(18), Ni–N(1) = 2.036(2), Ni–N(2) = 2.022(2); O(1)–Ni–O(3) = 177.19(7), N(1)–Ni–O(6) = 167.52(8), N(2)–Ni–O(5) = 165.36(8). Ellipsoids 50% probability level. carboxylates (O(1) and O(3)) to generate infinite chains. Each of the non-bonded oxygen atoms of the carboxylates (O(2) and O(4)) are associated by means of hydrogen bonds to two crystallization water molecules. In the case of 8a-Zn(II) the crystals of the meso-complex reveal a distorted trigonal bipyramid geometry around the metal center, with N(1) and O(3) occupying the apical positions (N(1)–Zn– O(3) 171.96(15)), and N(2), O(1) and the water molecule (O(7)) in the equatorial plane (Fig. 7). In this case the ether oxygen atoms of the ligand do not coordinate to the metal and the zinc atom is placed outside the cavity formed by the macrocyclic ligand. There are intramolecular O ◊ ◊ ◊ H bonds between both ether oxygen atoms (O(6) and O(5)) and the hydrogen atom of one of the NH groups (H(22)). An extended view of the structure (Fig. 8) indicates also intermolecular interactions between the other NH- hydrogen atom of the molecule (H(21)) and the oxygen atom O(1) of the neighboring molecule, and between an OH-hydrogen atom of the coordinated water molecule O(7) and the oxygen O(2) of the neighboring molecule to generate infinite chains. The X-ray structure of 8a-Cu(II) (Fig. 9) consists of two Cu(II) centres bridged by two oxygen atoms of the carboxylate groups. The dimer exhibits a (m2-oxo) Cu(1)O2Cu(1A) ring with Fig. 4 (A) Experimental (left) and theoretical (right) isotopic distribution of [M+Na]+ of 8b-Zn(II) complex. (B) Experimental (left) and theoretical (right) isotopic distribution of [M+Na]+ of 8b-Ni(II) complex. This journal is © The Royal Society of Chemistry 2011 Dalton Trans., 2011, 40, 9145–9153 | 9147 D ow nl oa de d by In sti tu to d e M ic ro bi ol og ía B io qu ím ic a on 0 5 Se pt em be r 2 01 1 Pu bl ish ed o n 08 A ug us t 2 01 1 on h ttp :// pu bs .rs c. or g | d oi :1 0. 10 39 /C 1D T1 05 39 F View Online http://dx.doi.org/10.1039/c1dt10539f Fig. 6 Crystal packing of 8a-Ni(II) showing the H bonding pattern (blue atoms, N; red, O; green, Ni). Hydrogen atoms not involved in hydrogen bonding as well as water crystallization molecules not involved in hydrogen bonding with the complex have been omitted for clarity. Fig. 7 Molecular diagram of complex 8a-Zn(II). Selected bond lengths (Å) and angles (deg): Zn–O(1) = 2.003(3), Zn–O(3) = 2.018(3), Zn–O(7) = 2.018(3), Zn–N(1) = 2.100(4), Zn–N(2) = 2.072(4); N(1)–Zn–O(3) = 171.96(15), O(1)–Zn–N(2) = 129.61(15), N(2)–Zn–O(7) = 116.00(16), O(1)–Zn–O(7) = 114.39(14), N(1)–Zn–O(1) = 80.41(15), N(1)–Zn–O(7) = 96.09(15), N(1)–Zn–N(2) = 95.00(15), O(3)–Zn–O(1) = 95.55(14), O(3)–Zn–O(7) = 91.91(15), O(3)–Zn–N(2) = 82.17(14) .Ellipsoids 50% probability level. a Cu ◊ ◊ ◊ Cu separation of 3.4959(18) Å and bridging angles of 81.4(2)◦ (O(3)–Cu–O(3A)) and 98.6(2)◦ (Cu(1)–O(3)–Cu(1A)). The geometry around each copper center can be described as a distorted octahedron. The equatorial positions are occupied by the nitrogen atoms N(1) and N(2) (Cu(1)–N(1) 1.998(6), Cu(1)–N(2) 1.974(6) Å) and by the carboxylate oxygen atoms O(3) and O(4) (Cu(1)–O(3) 1.947(5), Cu(1)–O(4) 1.919(6) Å). The axial positions are occupied by the ether atom O(1) and a bridging carboxylate oxygen of the neighbouring ligand bonded to Cu(1A) (Cu(1)– Fig. 8 Crystal packing of 8a-Zn(II) showing the H bonding pattern (blue atoms, N; red, O; purple, Zn). Hydrogen atoms not involved in hydrogen bonding as well as solvent crystallization molecules have been omitted for clarity. Fig. 9 Molecular diagram of complex 8a-Cu(II). Selected bond lengths (Å) and angles (deg): Cu(1)–O(3) = 1.947(5), Cu(1)–O(4) = 1.919(6), Cu(1)–N(1) = 1.998(6), Cu(1)–N(2) = 1.974(6), Cu(1)–O(3A) = 2.627(5), Cu(1)–O(1) = 2.744(7), Cu(1) ◊ ◊ ◊ Cu(1A) = 3.4959(18); O(3)–Cu(1)–N(1) = 172.3(2), O(4)–Cu(1)–N(2) = 176.6(2), O(4)–Cu(1)–N(1) = 85.1(2), N(1)–Cu(1)–N(2) = 98.1(2), O(1)–Cu(1)–O(3A) = 153.3(2). Ellipsoids 50% probability level. O(1) = 2.744(7), Cu(1)–O(3A) = 2.627(5) Å). The neighbouring ligands are connected by means of hydrogen bonding between the hydrogen atom of N(1) and the non-coordinating carboxylate 9148 | Dalton Trans., 2011, 40, 9145–9153 This journal is © The Royal Society of Chemistry 2011 D ow nl oa de d by In sti tu to d e M ic ro bi ol og ía B io qu ím ic a on 0 5 Se pt em be r 2 01 1 Pu bl ish ed o n 08 A ug us t 2 01 1 on h ttp :// pu bs .rs c. or g | d oi :1 0. 10 39 /C 1D T1 05 39 F View Online http://dx.doi.org/10.1039/c1dt10539f oxygen atom O(5) and between the hydrogen atom of N(2) and the carboxylate oxygen atom O(4). An extended view of the structure (Fig. 10) also indicates intermolecular interactions between the hydrogen atom of N(1) and the non-coordinating carboxylate oxygen atom O(5) of the neighbouring dimer, generating infinite chains.22 Fig. 10 Crystal packing of 8a-Cu(II) showing the H bonding pattern (blue atoms, N; red, O; orange, Cu). Hydrogen atoms not involved in hydrogen bonding as well as solvent crystallization molecules have been omitted for clarity. The structures of the metal complexes 8a-Ni(II), 8a-Zn(II) and 8a-Cu(II) are a good example of how a chiral macrocycle can modulate its binding properties depending not just on the size of the cavity, or the number and type of the donor atoms, but also on the geometry imposed by their stereogenic centers. Thus, in the octahedral racemic-8a-Ni(II) all N,O donor atoms are involved in a hexacoordinate complex, placing the metal inside the cavity. By contrast, the meso-complexes 8a-Zn(II) and 8a-Cu(II), having the same cavity size and donor atoms, show arrangements that place the metal outside the macrocycle. Examples of both, coordination and non-coordination of the ether oxygen atoms with the metal, have been reported for Ni(II) complexes derived from N-branched (N-CH2CH2OH and N-CH2CONH2) macrocycles23 having size cavities and N,O mixed donor atoms as in 8a.24 The formation of different diastereomeric complexes depending on the metal ion could constitute an a la carte method for the separation of the isomeric cavities 8. To test this point, crystals of the 8a-Cu(II) complex were treated with KOH (20% w/w in water) and after acidulation and filtration of the salts formed, pure macrocycle meso-8a could be obtained (the 1H-NMR spectrum showed the characteristic singlet at 5.42 ppm for this isomer). Conclusions An efficient approach for the synthesis of C-branched macro- cycles with (N,O) mixed donor atoms is described. Starting from macrocyclic diimines and by means of a Strecker reaction and subsequent hydrolysis, macrocyclic bis-a-aminoacids 8 were prepared in good yields. These new compounds are small chiral (racemic) molecules analogous to constrained a-aminoacids and have shown their ability to form complexes with Cu(II), Zn(II) and Ni(II). The structures of the metal complexes racemic-8a-Ni(II), meso-8a-Zn(II) and meso-8a-Cu(II) are a good example of how a chiral macrocycle can modulate its metal binding properties depending not just on the size of the cavity, or the number and type of the donor atoms, but also on the geometry imposed by their stereogenic centers, leading to different diastereomerically pure complexes. As far as we are aware, these are the first metal complexes derived from C-branched polyazamacrocyclic cavities reported in the literature. Experimental General procedures Diimines 9 and 10 were prepared following the previously reported procedures.25 1H NMR and 13C NMR spectra were recorded at 22 ◦C on Bruker Avance 300 (300.1 and 75.4 MHz) or Bruker 200- AC (200.1 and 50 MHz) spectrometers. Chemical shifts are given in ppm relative to CDCl3 (1H, 7.27 ppm) and CDCl3 (13C, 77.0 ppm); D2O (1H, 4.60 ppm), and D2O/Na2CO3 (13C, 165.0 ppm). IR spectra were taken on a Bruker Tensor 27 (MIR 8000–400 cm-1) spectrometer. Mass spectra were recorded on a QSTAR pulsar I, (hybrid analyzed QTOF, applied biosystems) (ESI), or a MAT 95 XP ThermoFinnigan (FAB) apparatus. CH2Cl2was distilled from calcium hydride and THF from sodium-benzophenone. Flame- dried glassware and standard Schlenk techniques were used for moisture sensitive reactions. All commercially available organic reagents were used without further purification. Caution: HCN is produced by reaction of trimethylsilyl cyanide (TMSCN) with acid, water or protic solvents. All reactions using this reagent should be carried out using the adequate precautions in well ventilated hoods. Diimine 11. Was obtained as yellow oil (1.05 g, 90%) by reflux- ing 1,3-bis(2-formylphenyl)-1,3-dioxapropane (1.0 g, 3.7 mmol)25 and (0.3 g, 3.7 mmol) 1,4-diamine-2-butyne in 500 cm3 MeOH for 24 h. 1H NMR (300 MHz, CDCl3) d 9.22 (s, 2H, CH N), 7.92 (dd, J1 = 7.6 Hz, J2 = 1.6 Hz, 2H, ArH), 7.42–7.36 (m, 2H, ArH), 7.07–6.96 (m, 4H, ArH), 4.69 (s, 4H, CH2–N), 4.24 (t, J = 5.9 Hz, 4H, CH2O), 2.36 (q, J = 5.9 Hz, 2H, CH2). 13C-NMR (50 MHz, CDCl3) d 158.2 (C N), 158.0, 131.9, 127.5, 125.8, 121.7, 114.0 (ArC), 82.8 (C), 67.3 (CH2O), 47.3 (CH2N), 28.5 (CH2). IR (Film) nmax 3070, 2891, 2217, 1640, 1597, 1293, 1240, 1108, 1058, 754 cm-1. ESI-MS: 333.1 [M+H]+. Diimine 12. Was obtained as pale yellow oil (1.27 g, 93%) by refluxing 1,2-bis(2¢-formylphenyl)-1,3-dioxaethane (1.0 g, 3.56 mmol)25 and a,a¢-diamine-m-xylene (0.48 g, 3.56 mmol) in 500 cm3 MeOH for 24 h. 1H NMR (300 MHz, CDCl3) d 8.76 (s, 2H, CH N), 7.84 (d, J = 7.6 Hz, 2H, ArH), 7.36–7.28 (m, 2H, ArH), 7.20 (m, 4H, ArH) 7.06–6.95 (m, 4H, ArH), 4.67 (s, 4H, CH2O), 4.34 (s, 4H, CH2–N). 13C NMR (50 MHz, CDCl3) d 158.8 (C N), 157.5, 138.1, 131.6, 128.5, 128.1, 127.9, 127.6, 125.2, 121.1, 110.9 (ArC), 65.8 (CH2O), 64.3 (CH2N). IR (Film) nmax 3018, 2935, 1634, 1598, 1485, 1450, 1290, 1242, 1111, 1062, 751 cm-1. General procedure for the synthesis of bis-aminonitriles 13–16 To a solution of the corresponding diimine in anhydrous THF, under an argon atmosphere and at 0 ◦C, TMSCN was added in a 1 : 3 molar ratio. The reaction mixture was stirred at 0 ◦C for This journal is © The Royal Society of Chemistry 2011 Dalton Trans., 2011, 40, 9145–9153 | 9149 D ow nl oa de d by In sti tu to d e M ic ro bi ol og ía B io qu ím ic a on 0 5 Se pt em be r 2 01 1 Pu bl ish ed o n 08 A ug us t 2 01 1 on h ttp :// pu bs .rs c. or g | d oi :1 0. 10 39 /C 1D T1 05 39 F View Online http://dx.doi.org/10.1039/c1dt10539f 30 min, then at room temperature for 20 h, quenched at 0 ◦C with NH4Cl (10 cm3, sat. soln.) and extracted with CH2Cl2 (2 ¥ 100 cm3). The combined organic extracts were washed with water, brine and dried over MgSO4. The solution was filtered and the solvent was removed under vacuum. Bis-aminonitriles 13–16 were obtained in nearly quantitative yields as unstable oils and were used in the following step without further purification. Bis-aminonitrile 13. From 0.64 g (2.1 mmol) of diimine 9 and 0.8 cm3 (6.3 mmol) TMSCN, bis-aminonitrile 13 was obtained in quantitative yield (0.75 g) as pale yellow oil and as a 1 : 2 (meso/racemic) diastereomeric mixture. 1H NMR (200 MHz, CDCl3) d 7.53–7.34 (m, 4H, ArH), 7.06–6.85 (m, 4H, ArH), 5.02 (s, 0.7H, CH, meso), 4.84 (s, 1.3H, CH, racemic), 4.44 (s, 4H, CH2O), 3.01–2.90 (m, 2H, CH2N), 2.76–2.65 (m, 2H, CH2N), 1.89–1.79 (m, 2H, CH2).13C NMR (75 MHz, CDCl3) d 155.9, 155.4, 130.7, 130.5, 129.5, 129.1, 122.9, 122.8, 121.9 (ArC), 118.6, 118.7 (CN), 111.1, 110.0 (ArC), 65.9, 65.5 (CH2O), 51.9, 51.1 (CH2N), 47.5, 46.1 (CH), 25.5, 25.0 (CH2). IR (KBr) nmax 3309, 3018, 2929, 2229 (w), 1597, 1494, 1453, 1249, 1113, 1060, 753 cm-1. Bis-aminonitrile 14. From 1.0 g (3.1 mmol) of diimine 10 and 1.25 cm3 (9.3 mmol) TMSCN, bis-aminonitrile 14 was obtained in quantitative yield (1.16 g) as pale yellow oil and as a 1 : 1 (meso/racemic) diastereomeric mixture. 1H NMR (200 MHz, CDCl3) d 7.48–7.26 (m, 4H, ArH), 7.06–6.86 (m, 4H, ArH), 5.01 (s, 1H, CH meso), 4.83 (s, 1H, CH racemic), 4.42–4.28 (m, 4H, CH2O), 2.94–2.67 (m, 4H, CH2N), 2.35–2.28 (m, 2H, CH2), 1.76– 1.65 (m, 2H, CH2). 13C NMR (50 MHz, CDCl3) d 156.3, 156.2, 130.7, 130.6, 129.4, 128.9, 124.8, 124.2, 121.7, 121.4, 121.1 (ArC), 119.1, 118.9 (CN), 114.5, 114.1 (ArC), 66.7, 65.9 (CH2O), 51.2, 49.9 (CH), 46.2, 46.1 (CH2N), 29.8, 29.6, 28.3 (CH2). IR (KBr) nmax 3310, 3018, 2930, 2230 (w), 1597, 1495, 1453, 1371, 1249, 1110, 1060, 938, 754 cm-1. Bis-aminonitrile 15. From 1.2 g (3.1 mmol) of diimine 11 and 1.25 cm3 (9.3 mmol) TMSCN, bis-aminonitrile 15 was obtained in quantitative yield (1.19 g) as pale yellow oil and as a 1 : 1 (meso/racemic) diastereomeric mixture. 1H NMR (300 MHz, CDCl3) d 7.58–7.46 (m, 1H, ArH), 7.40–7.33 (m, 3H, ArH), 7.08–6.95 (m, 4H, ArH), 5.33 (s, 1H, CH meso), 5.20 (s, 1H, CH racemic), 4.34–4.26 (m, 4H, CH2O), 3.64 (s, 2H, CH2–N), 3.59 (s, 2H, CH2N), 2.43–2.31 (m, 2H, CH2).13C NMR (75 MHz, CDCl3) d 155.7, 155.6, 130.8, 130.7, 130.5, 129.1, 128.8, 124.8, 123.6, 121.7, 121.6 (ArC), 118.6, 118.5 (CN), 113.1, 113.0 (ArC), 80.8, 80.7 (C), 65.1, 65.0 (CH2O), 48.5, 47.9 (CH), 36.7, 36.6 (CH2N), 29.1, 29.0 (CH2). IR (KBr) nmax 3329, 3017, 2931, 2226 (w), 1599, 1492, 1451, 1245, 1114, 1061, 751 cm-1. Bis-aminonitrile 16. From 0.8 g (2.5 mmol) of diimine 12 and 0.92 cm3 (7.5 mmol) TMSCN, bis-aminonitrile 16 was obtained in quantitative yield (1.05 g) as pale yellow oil and as a 1 : 1 (meso/racemic) diastereomeric mixture. 1H NMR (300 MHz, CDCl3) d 7.54–7.47 (m, 2H, ArH), 7.40–7.21 (m, 6H, ArH), 7.08– 7.00 (m, 2H, ArH), 6.95–6.89 (m, 2H, ArH), 4.98 (s, 1H, CH meso), 4.91 (s, 1H, CH racemic), 4.43–4.35 (m, 4H, CH2–O), 4.07–3.85 (m, 4H, CH2–N). 13C NMR (75 MHz, CDCl3) d 155.5, 155.3, 138.3, 138.2, 130.4, 130.3, 128.8, 128.5, 128.4, 128.3, 128.2, 128.1, 127.2, 123.2, 123.0, 121.4 (ArC), 118.9, 118.8 (CN), 67.8, 67.7 (CH2O), 51.0, 51.8 (CH2N), 47.8, 47.5 (CH). IR (KBr) nmax 3315, 3020, 2936, 2229 (w), 2217, 1598, 1495, 1450, 1243, 1110, 1058, 751 cm-1. General procedure for the synthesis of bis-aminoacids 8a–d Concentrated aqueous HCl (12 M) (15–20 cm3) was added over the freshly prepared bis-aminonitrile. The mixture was heated at 50–60 ◦C for 2 h and then water (20 cm3) was added and the resultant mixture was refluxed for 4 h. The solution was filtered and the solvent removed under reduced pressure. The solid obtained was washed with acetone and dried. Bis-aminoacids 8a–d were obtained as hydrochlorides, and as a mixture of meso/racemic isomers. Bis-a-aminoacid 8a. Following the general procedure, 635 mg (65% from imine 9) bis-a-aminoacid 8a was obtained as a pale pink solid and as a 1 : 2 (meso/racemic) diastereomeric mixture. 1H NMR (200 MHz, D2O) d 7.57–7.50 (m, 2H, ArH), 7.38– 7.33 (m, 2H, ArH), 7.23–7.08 (m, 4H, ArH), 5.48 (s, 1.3H, CH, racemic), 5.42 (s, 0.7H, CH, meso), 4.65–4.50 (m, 4H, CH2O), 3.16–2.87 (m, 4H, CH2N), 2.61–2.43 (m, 1H, CH2), 2.20–1.98 (m, 1H, CH2). 13C NMR (75 MHz, D2O/Na2CO3) d 180.4, 180.3 (C O), 161.4, 161.0, 135.9, 135.8, 135.4, 135.2, 128.0, 127.9, 126.4, 126.3, 117.1, 117,0 (ArC), 71.8, 71.4 (CH2O), 66.2, 66.0 (CH), 50.0, 49.9 (CH2N), 29.3, 29.2 (CH2). IR (KBr) nmax 3410, 3126, 2936, 1734, 1632, 1495, 1452, 1403, 1330, 1252, 1117, 766 cm-1. ESI-MS: 401.3 [M+H]+; HRMS (ESI): calc for C21H24N2O6: 400.1634; found 400.1631. Bis-a-aminoacid 8b. Following the general procedure, 1.1 g (73% from imine 10) bis-a-aminoacid 8b was obtained as a pale pink solid and as a 1 : 1 (meso/racemic) diastereomeric mixture. 1H NMR (200 MHz, D2O) d 7.52–7.05 (m, 8H, ArH), 5.32 (s, 1H, CH, racemic), 5.29 (s, 1H, CH, meso), 4.40–4.05 (m, 4H, CH2O), 3.07–2.50 (m, 4H, CH2N), 2.20–1.60 (m, 4H, CH2). 13C NMR (75 MHz, D2O/Na2CO3) d 179.4, 179.2 (C O), 161.8, 161.5, 136.2, 136.0, 135.7, 135.3, 128.8, 127.8, 127.1, 126.4, 119.0, 118,3 (ArC), 72.2, 69.8 (CH2O), 65.8, 65.6 (CH), 51.6, 48.9 (CH2N), 33.8, 32.6, 29.3, 29.2 (CH2). IR (KBr) nmax 3265, 2883, 1753, 1635, 1598, 1560, 1485, 1240, 1110, 1031 cm-1. ESI-MS: 415.2 [M+H]+; HRMS (ESI): calc for C22H26N2O6: 414.1791; found 414.1784. Bis-a-aminoacid 8c. Following the general procedure, 1.18 g (66% from imine 11) bis-a-aminoacid 8c was obtained as a pale pink solid and as a 1 : 1 (meso/racemic) diastereomeric mixture. 1H NMR (300 MHz, D2O) d 7.39–6.88 (m, 8H, ArH), 5.37 (s, 1H, CH, racemic), 5.27 (s, 1H, CH, meso), 4.29–4.08 (m, 4H, CH2O), 3.75 (s, 2H, CH2N), 3.74 (s, 2H, CH2N), 2.19–2.08 (m, 2H, CH2). 13C NMR (125 MHz, D2O/Acetone d6) d 170.4, 170.2 (C O), 157.1, 133.1, 132.9, 130.1, 129.4, 123.0, 122.9, 119.1, 114.8, 113,9 (ArC), 79.0, 78.8 (C), 67.5, 65.7 (CH2O), 57.8, 57.3 (CH), 35.5, 35.4 (CH2N), 29.4, 28.5 (CH2). IR (KBr) nmax 3387, 2944, 2803, 1746, 1652, 1598, 1559, 1494, 1248, 1100, 1049 cm-1. ESI-MS: 425.1 [M+H]+; HRMS (ESI): calc for C23H25ClN2O6:460.1401; found 460.1414. Bis-a-aminoacid 8d. Following the general procedure, 700 mg (61% from imine 12) bis-a-aminoacid 8d was obtained as a pale yellow solid and as a 1 : 1 (meso/racemic) diastereomeric mixture. 1H NMR (300 MHz, D2O) d 784 (s, 1H, ArH), 7.56–7.37 (m, 6H, ArH), 7.23–7.10 (m, 5H, ArH), 5.43 (s, 1H, CH, racemic), 5.31 9150 | Dalton Trans., 2011, 40, 9145–9153 This journal is © The Royal Society of Chemistry 2011 D ow nl oa de d by In sti tu to d e M ic ro bi ol og ía B io qu ím ic a on 0 5 Se pt em be r 2 01 1 Pu bl ish ed o n 08 A ug us t 2 01 1 on h ttp :// pu bs .rs c. or g | d oi :1 0. 10 39 /C 1D T1 05 39 F View Online http://dx.doi.org/10.1039/c1dt10539f (s, 1H, CH, meso), 4.44–4.14 (m, 8H, CH2O + CH2N). 13C NMR (75 MHz, D2O/Na2CO3) d 179.5 (C O), 159.5, 159.3, 139.0, 138.8, 133.3, 132.8, 132.7, 132.4, 132.1, 128.9, 128.3, 125.2, 124.8, 117.1, 116.0 (ArC), 71.2, 70.9 (CH2O), 63.2, 63.1 (CH), 52.9, 52.7 (CH2N). IR (KBr) nmax 3392, 2929, 2813, 1743, 1652, 1558, 1494, 1251, 1112, 1049 cm-1. ESI-MS: 463.1 [M+H]+. HRMS (ESI): calc for C26H26N2O6 ([M+H]+): 462.1791; found 462.1790. General procedure for the synthesis of metal complexes A solution of the corresponding bis-aminoacid hydrochloride 8a–d in water was adjusted to pH 8.5 with 10% NaOH. Then, a solution of the corresponding metallic salt in 2–3 cm3 of water was added, slowly, dropwise, maintaining the pH 8.5 by successive additions of 5% NaOH and 5% HCl. The molar ratio aminoacid/metal salt was 1 : 1. After the addition, the solution was adjusted to pH 7 and the mixture was kept in the refrigerator overnight. The solution was filtered (0.45 mm membrane) and the solvent was removed under vacuum, to yield the metal complexes, which were analyzed by ESI-MS or FABMS. Cu(II)-8a. Following the general procedure, from bis-a- aminoacid 8a (0.41 mmol, 200 mg) and CuCl2·2H2O (0.41 mmol, 68 mg). The Cu(II) complex was obtained as a dark blue solid (145 mg, 75%). ESI-MS: 484.0 [M+Na]+, 461.9 [M+H].+ IR (KBr) nmax 3405, 3215, 2951, 1617, 1601, 1492, 1384, 1245, 1110, 834 cm-1. HRMS (ESI): calc for C21H22N2O6Cu: 461.0774; found 461.0785. Cu(II)-8b. Following the general procedure, from bis-a- aminoacid 8b (0.42 mmol, 200 mg) and CuCl2·2H2O (0.42 mmol, 70 mg). The Cu(II) complex was obtained as a dark blue solid (140 mg, 72%). ESI-MS: 498.0 [M+Na]+, 476.0 [M+H]+. IR (KBr) nmax 3415, 3210, 2921, 1618, 1603, 1494, 1384, 1244, 1111, 833 cm-1. HRMS (ESI): calc for C22H24N2O6Cu: 475.0930; found 475.0942. Zn(II)-8a. Following the general procedure, from bis-a- aminoacid 8a (0.41 mmol, 200 mg) and Zn(NO3)2·6H2O (0.41 mmol, 120 mg). The Zn(II) complex was obtained as a pale yellow solid (123 mg, 65%). 1H NMR (700 MHz, D2O/MeOD) d 7.59-7-38 (m, 4H, ArH), 7.30-7.07 (m, 4H, ArH), 4.70-4.44 (m, 4H, CH2O), 3.24-3.03 (m, 2H, CH2N), 3.02-2.90 (m, 2H, CH2N), 2.73-2.64 (m, 2 H, CH2). 13C NMR (176 MHz, D2O/MeOD) d 181.3, 179.6 (C=O), 158.6, 156.3, 136.6, 133.4, 132.3, 131.2, 128.6, 125.5, 123.3, 122.7, 114.5, 114.0 (ArC), 70.0, 68.9 (CH2O), 66.0, 63.5 (CH), 48.6, 45.8 (CH2N), 28.2 (CH2). FABMS: 482.5 [M+H2O+H]+. IR (KBr) nmax 3446, 3133, 2935, 1643, 1609, 1495, 1384, 1248, 1118, 835 cm-1. HRMS (ESI): calc for C21H22N2O6Zn: 462.0769; found 462.0761. Zn(II)-8b. Following the general procedure, from bis-a- aminoacid 8b (0.42 mmol, 200 mg) and Zn(NO3)2·6H2O (0.42 mmol, 124 mg). The Zn(II) complex was obtained as a pale yellow solid (140 mg, 70%). 1H NMR (700 MHz, D2O/MeOD) d 7.53-6.98 (m, 8H, ArH), 4.54-4.45 (m, 1H, CH2O), 4.44-4.31 (m, 2H, CH2O), 4.28-4.19 (m, 1H, CH2O) 3.13-2.64 (m, 4H, CH2N), 2.54-2.36 (m, 2H, CH2), 2.14-2.02 (m, 2 H, CH2). 13C NMR (176 MHz, D2O/MeOD) d 179.7, 178.4 (C=O), 158.2, 155.3, 134.9, 131.8, 130.8, 129.7, 126.0, 122.9, 120.5, 119.1, 112.9, 111.6 (ArC), 74.1, 67.9 (CH2O), 64.7, 61.6 (CH), 48.3, 44.8 (CH2N), 28.8, 26.3 (CH2). ESI-MS: 499.1 [M+Na]+, 477.1 [M+H]+. IR (KBr) nmax 3441, 3140, 2925, 2853, 1632, 1601, 1493, 1384, 1250, 1111, 835, 760 cm-1. HRMS (ESI): calc for C22H24N2O6Zn: 476.0926; found 476.0927. Ni(II)-8a. Following the general procedure, from bis-a- aminoacid 8a (0.41 mmol, 200 mg) and Ni(NO3)2·6H2O (0.41 mmol, 118 mg). The Ni(II) complex was obtained as a green solid (120 mg, 63%). ESI-MS: 479.2 [M+Na]+, 457.3 [M+H]+. IR (KBr) nmax 3390, 3175, 2935, 1631, 1602, 1494, 1384, 1249, 1111, 834, 757 cm-1. HRMS (ESI): calc for C21H22N2O6Ni: 456.0831; found 456.0858. Ni(II)-8b. Following the general procedure, from bis-a- aminoacid 8b (0.42 mmol, 200 mg) and Ni(NO3)2·6H2O (0.42 mmol, 121 mg). The Ni(II) complex was obtained as a green solid (115mg, 60%). ESI-MS: 493.1 [M+Na]+, 471.1 [M+H]+. IR (KBr) nmax 3386, 3187, 1633, 1601, 1492, 1384, 1246, 1111, 1052, 834, 757 cm-1. C22H24N2O6Ni: 470.0988; found 470.1013 X-Ray data collection and structure refinement of complexes 8a-Ni(II), 8a-Zn(II) and 8a-Cu(II) Crystals suitable for the X-ray diffraction were obtained by crys- tallization in MeOH/CH3CN/H2O (8a-Ni(II)) and MeOH/H2O (8a-Zn(II) and 8a-Cu(II)). X-Ray data were collected on a Bruker Smart APEX CCD diffractometer equipped with a normal focus, 2.4 kW sealed tube source (Mo radiation, l = 0.71073 Å) operating at 50 kV and 30 mA. Data were collected over the complete sphere by a combination of four sets. Each frame exposure time was 10 s (8a-Ni(II), 8a-Cu(II)) or 30 s (8a-Zn(II)) covering 0.3◦ in w. Data were corrected for absorption by using a multiscan method applied with the SADABS program.26 The structures were solved by the Patterson method. Refinement, by full-matrix least squares on F 2 with SHELXL97,27 was similar for all complexes, including isotropic and subsequently anisotropic displacement parameters. The hydrogen atoms were observed or calculated and refined freely or using a restricted riding model. A methylene group (C10) of 8a- Ni(II) was found to be disordered and was refined with an isotropic model in two positions (0.5/0.5). For 8a-Ni(II) seven molecules of water were observed in the asymmetric unit as crystallization solvent. For 8a-Zn(II), 2.5 (water) and 0.5 (ethanol) molecules were observed in the asymmetric unit as crystallization solvents. For 8a- Cu(II) three molecules of water were observed in the asymmetric unit as crystallization solvent. All the highest electronic residuals were observed in the close proximity of the metal centers and make no chemical sense. Crystal data for 8a-Ni(II): C21H22N2NiO6·7(H2O), MW 583.23, blue, prism (0.12 ¥ 0.10 ¥ 0.08), monoclinic, space group P21/n, a: 10.5486(10) Å, b: 16.1100(15) Å, c: 15.8867(15) Å, a: 90.00◦, b: 108.0310(10)◦, g : 90.00◦, V = 2567.2(4) Å3, Z = 4, Dcalc: 1.509 g cm-3, F(000): 1232, T = 173(2) K, m = 0.825 mm-1. 27 115 measured reflections (2q: 3–57◦, w scans 0.3◦), 6253 unique (Rint = 0.0933); min./max. transm. factors 0.766/0.940. Final agreement factors were R1 = 0.0429 (3550 observed reflections, I > 2s(I)) and wR2 = 0.0958; data/restraints/parameters 6253/7/376; GoF = 0.892. Largest peak and hole 0.494 and -0.412 e Å-3. Crystal data for 8a-Zn(II): C21H24N2O7Zn·0.5(C2H6O)· 2.5(H2O), MW 549.87, colorless, needle(0.20 ¥ 0.06 ¥ 0.05), monoclinic, space group P21, a: 11.7777(11) Å, b: 7.4694(7) Å, c: 14.6265(13) Å, a: 90.00◦, b: 107.0520(10)◦, g : 90.00◦, This journal is © The Royal Society of Chemistry 2011 Dalton Trans., 2011, 40, 9145–9153 | 9151 D ow nl oa de d by In sti tu to d e M ic ro bi ol og ía B io qu ím ic a on 0 5 Se pt em be r 2 01 1 Pu bl ish ed o n 08 A ug us t 2 01 1 on h ttp :// pu bs .rs c. or g | d oi :1 0. 10 39 /C 1D T1 05 39 F View Online http://dx.doi.org/10.1039/c1dt10539f V = 1230.2(2) Å3, Z = 2, Dcalc: 1.484 g cm-3, F(000): 576, T = 173(2) K, m = 1.056 mm-1. 11 233 measured reflections (2q: 3–58◦, w scans 0.3◦), 5872 unique (Rint = 0.0747); min./max. transm. factors 0.857/0.925. Final agreement factors were R1 = 0.0508 (4290 observed reflections, I > 2s(I)) and wR2 = 0.1263; data/restraints/parameters 5872/9/328; GoF = 0.963. Largest peak and hole 1.165 and -0.522 e Å-3. Crystal data for 8a-Cu(II): C42H44Cu2N4O12·3H2O, MW 977.94, blue, prism (0.25 ¥ 0.12 ¥ 0.12), monoclinic, space group C2/c, a: 13.4667(13) Å, b: 21.127(2) Å, c: 16.2489(17) Å, a: 90.00◦, b: 92.054(2)◦, g : 90.00◦, V = 4620.1(8) Å3, Z = 4, Dcalc: 1.466 g cm-3, F(000): 2032, T = 296(2) K, m = 0.990 mm-1. 18 880 measured reflections (2q: 3–52◦, w scans 0.3◦), 4511 unique (Rint = 0.1579); min./max. transm. factors 0.850/1.0. Final agreement factors were R1 = 0.0739 (2130 observed reflections, I > 2s(I)) and wR2 = 0.2682; data/restraints/parameters 4511/0/285; GoF = 1.034. Largest peak and hole 1.567 and -0.382 e Å-3. Acknowledgements Support for this work under grants CTQ-2010-20714-C02- 01/BQU to MAS, CTQ2008-00810 to MO and Consolider Ingenio 2010 CSD2007-00006 from the MICINN (Spain) and P2009/PPQ1634-AVANCAT from the Comunidad de Madrid (CAM) is gratefully acknowledged. PRL thanks the CSIC for a JAE post-doctoral grant. We would also like to thank Prof. Ángel Gutiérrez Alonso for fruitful discussions. Notes and references 1 Reviews: (a) P. A. Vigato, S. Tamburini and L. Bertolo, Coord. Chem. Rev., 2007, 251, 1311; (b) J. P. Danks, N. R. Champness and M. Schröder, Coord. Chem. Rev., 1998, 174, 417; (c) A. Bencini, A. Bianchi, P. Paoletti and P. Paoli, Coord. Chem. Rev., 1992, 120, 51; (d) R. Hancock and A. E. Martell, Chem. Rev., 1989, 89, 1875. Some recent representative articles: (e) M. C. Aragoni, M. Arca, A. Bencini, S. Biagini, A. J. Blake, C. Caltagirone, F. Demartin, G. De Filippo, F. A. Devillanova, A. Garau, K. Gloe, F. Isaia, V. Lippolis, B. Valtancoli and M. Wenzel, Inorg. Chem., 2008, 47, 8391; (f) S. P. Gavrish, Y. D. Lampeka, P. Lightfoot and H. Pritzkow, Dalton Trans., 2007, 4708; (g) C. Bazzicalupi, A. Bencini, A. Bianchi, C. Duce, P. Fornasari, C. Giorgi, P. Paoletti, R. Pardini, M. R. Tinè and B. Valtancoli, Dalton Trans., 2004, 463; (h) J. D. Lewis and J. N. Moore, Dalton Trans., 2004, 1376; (i) C. Caltagirone, A. Bencini, F. Demartin, F. A. Devillanova, A. Garau, F. Isaia, V. Lippolis, P. Mariani, U. Papke, L. Tei and G. Verani, Dalton Trans., 2003, 901; (j) A. Bencini, E. Berni, A Bianchi, C. Giorgi, B. Valtancoli, D. K. Chand and H. J. Schneider, Dalton Trans., 2003, 793; (k) L. Tei, M. Arca, M. C. Aragoni, A. Bencini, A. J. Blake, C. Caltagirone, F. A. Devillanova, P. Fornasari, A. Garau, F. Isaia, V. Lippolis, M. Schröder, S. J. Teat and B. Valtanconi, Inorg. Chem., 2003, 42, 8690; (l) G. Ambrosi, P. Dapporto, M. Formica, V. Fusi, L. Giorgi, A. Guerri, M. Micheloni, P. Paoli, R. Pontellini and P. Rossi, Chem.–Eur. J., 2003, 9, 800. 2 For the use of these structures in building supramolecular networks see: (a) M. P. Suh, Y. E. Cheon and Y. E. Lee, Coord. Chem. Rev., 2008, 252, 1007; (b) S. P. Gavrish, Y. D. Lampeka, H. Pritzkow and P. Lightfoot, Dalton Trans., 2010, 39, 7706. For a recent example of the use of these structures as enzyme mimics see: (c) W. C. Ellis, C. T. Tran, M. A. Denardo, A. Fischer, A. D. Ryabov and T. J. Collins, J. Am. Chem. Soc., 2009, 131, 18052 and references therein. 3 (a) J. Costamagna, G. Ferraudi, B. Matsuhiro, M. Campos-Vallette, J. Canales, M. Villagrán, J. Vargas and M. J. Aguirre, Coord. Chem. Rev., 2000, 196, 125; (b) M. Meyer, V. Dahaoui-Gindrey, C. Lecomte and R. Guilard, Coord. Chem. Rev., 1998, 178–180, 1313; (c) K. R. Adam, A. J. Leong, L. F. Lindoy, P. Hendry, S. V. Smith and D. Yellowlees, J. Coord. Chem., 1988, 19, 189. 4 See for example: (a) A. Rastogi and R. Nayan, J. Coord. Chem., 2009, 62, 3366; (b) C. Anda, A. Bencini, E. Berni, S. Ciattini, F. Chuburu, A. Danesi, C. Giorgi, H. Handel, M. Le Baccon, P. Paoletti, R. Tripier, V. Turcry and B. Valtancoli, Eur. J. Inorg. Chem., 2005, (11), 2044; (c) M. C. Aragoni, M. Arca, A. Bencini, A. J. Blake, C. Caltagirone, A. Decortes, F. Demartin, F. A. Devillanova, E. Faggi, L. S. Dolci, A. Garau, F. Isaia, V. Lippolis, L. Prodi, C. Wilson, B. Valtancoli and N. Zaccheroni, Dalton Trans., 2005, 2994; (d) M. P. Clares, J. Aguilar, R. Aucejo, C. Lodeiro, M. T. Albelda, F. Pina, J. C. Lima, A. J. Parola, J. Pina, J. Seixas de Melo, C. Soriano and E. Garcı́a-España, Inorg. Chem., 2004, 43, 6114; (e) A. M. Herrera, R. J. Staples, S. V. Kryatov, A. Y. Nazarenko and E. V. Rybak-Akimova, Dalton Trans., 2003, 846; (f) A. J. Blake, J. P. Danks, W-S. Li, V. Lippolis and M. Schröder, J. Chem. Soc., Dalton Trans., 2000, 3034; (g) L. Tei, A. J. Blake, A. Bencini, B. Valtancoli, C. Wilson and M. Schröder, J. Chem. Soc., Dalton Trans., 2000, 4122; (h) J. C. Tao, Y. J. Wu and J. Y. Song, Polyhedron, 1999, 18, 1015. 5 (a) R. Fenton, L. F. Lindoy, R. C. Luckay, F. R. Turville and G. Wei, Aust. J. Chem., 2001, 54, 59; (b) W. Clegg, P. B. Iveson and J. C. Lockhart, J. Chem. Soc., Dalton Trans., 1992, 3291. 6 A. Castries, A. Escande, H. Fensterbank, E. Magnier, J. Marrot and C. Larpent, Tetrahedron, 2007, 63, 10330. 7 Some references of metal complexes derived from N-carboxylic acid branched azamacrocycles: (a) J. Brunner, H. Pritzkow and R. Krämer, Dalton Trans., 2005, 338; (b) T. Gunnlaugsson, J. P. Leonard, S. Mulreadya and M. Nieuwenhuyzen, Tetrahedron, 2004, 60, 105; (c) E. Terreno, M. Botta, F. Fedeli, B. Mondino, L. Milone and S. Aime, Inorg. Chem., 2003, 42, 4891; (d) M. B. Inoue, H. Santacruz, M. Inoue and Q. Fernando, Inorg. Chem., 1999, 38, 1596; (e) S. L. Wu, K. A. Johnson and W. D. Horrocks, Inorg. Chem., 1997, 36, 1884; (f) J. Huskens, D. A. Torres, Z. Kovacs, J. P. Andre, C. F. G. C. Geraldes and A. D. Sherry, Inorg. Chem., 1997, 36, 1495; (g) J. Costa, R. Delgado, M. C. Figueira, R. T. Henriques and M. Teixeira, J. Chem. Soc., Dalton Trans., 1996, 65. Selected recent references for lanthanide complexes: (h) L. S. Natrajan, N. M. Khoabane, B. L. Dadds, C. A. Muryn, R. G. Pritchard, S. L. Heath, A. M. Kenwright, I. Kuprov and S. Faulkner, Inorg. Chem., 2010, 49, 7700; (i) L. S. Natrajan, A. J. L. Villaraza, A. M. Kenwright and S. Faulkner, Chem. Commun., 2009, 6020; (j) M. P. Placidi, A J. L. Villaraza, L. S. Natrajan, D. Sykes, A. M. Kenwright and S. Faulkner, J. Am. Chem. Soc., 2009, 131, 9916; (k) S. J. A. Pope, B. P. Burton-Pye, R. Berridge, T. Khan, P. J. Skabara and S. Faulkner, Dalton Trans., 2006, 2907; (l) K. Sénéchal-David, S. J. A. Pope, S. Quinn, S. Faulkner and T. Gunnlaugsson, Inorg. Chem., 2006, 45, 10040. 8 The iron complexes of macrocyclic polyaminocarboxylates have been tested as antitumor agents, see: (a) H.-S. Chong, H. A. Song, X. Ma, S. Lim, X. Sun and S. B. Mhaske, Chem. Commun., 2009, 3011; (b) H.-S. Chong, X. Ma, H. Lee, P. Bui, H. A. Song and N. Birch, J. Med. Chem., 2008, 51, 2208 and references therein. 9 Selected reviews: (a) S. Lee, J. Xie and X. Chen, Chem. Rev., 2010, 110, 3087; (b) T. J. Wadas, E. H. Wong, G. R. Weisman and C. J. Anderson, Chem. Rev., 2010, 110, 2858; (c) J. L. Major and T. J. Meade, Acc. Chem. Res., 2009, 42, 893; (d) S. Liu, Chem. Soc. Rev., 2004, 33, 445; (e) W. A. Volkert and T. J. Hoffman, Chem. Rev., 1999, 99, 2269; (f) P. Caravan, J. J. Ellison, T. J. McMurry and R. B. Lauffer, Chem. Rev., 1999, 99, 2293; (g) C. J. Anderson and M. J. Welch, Chem. Rev., 1999, 99, 2219; (h) J. A. Balschi, K. Clarke, L. C. Stewart, M. Bernard and J. S. Ingwall, in Methods in Biomedical Magnetic Resonance Imaging and Spectroscopy, ed. I. R. Young, Chichester, UK, 2000, vol. 2, pp. 871–879. 10 (a) J-C. G. Bünzli, Chem. Rev., 2010, 110, 2729; (b) C. P. Montgomery, B. S. Murray, E. J. New, R. Pal and D. Parker, Acc. Chem. Res., 2009, 42, 925; (c) D. Parker, Coord. Chem. Rev., 2000, 205, 109; (d) W. D. Horrocks and D. R. Sudnick, Acc. Chem. Res., 1981, 14, 384. 11 (a) R. Quevedo, I. Ortiz and A. Reyes, Tetrahedron Lett., 2010, 51, 1216; (b) S. E. Gibson, J. O. Jones, S. B. Kalindjian, J. D. Knight, N. Mainolfi, M. Rudd, J. W. Steed, M. J. Tozerb and P. T. Wright, Tetrahedron, 2004, 60, 6945; (c) J. W. Janetka and D. H. Rich, J. Am. Chem. Soc., 1997, 119, 6488. 12 S. Kotha, Acc. Chem. Res., 2003, 36, 342. 13 L. R. Pérez and K. J. Franz, Dalton Trans., 2010, 39, 2177. 14 (a) E. Gaggelli, H. Kozlowski, D. Valensin and G. Valensin, Chem. Rev., 2006, 106, 1995; (b) R. R. Crichton, D. T. Dexter and R. J. Ward, Coord. Chem. Rev., 2008, 252, 1189; (c) P. Faller and C. Hureau, Dalton Trans., 2009, 1080. 9152 | Dalton Trans., 2011, 40, 9145–9153 This journal is © The Royal Society of Chemistry 2011 D ow nl oa de d by In sti tu to d e M ic ro bi ol og ía B io qu ím ic a on 0 5 Se pt em be r 2 01 1 Pu bl ish ed o n 08 A ug us t 2 01 1 on h ttp :// pu bs .rs c. or g | d oi :1 0. 10 39 /C 1D T1 05 39 F View Online http://dx.doi.org/10.1039/c1dt10539f 15 See: (a) D. Pellico, M. Gómez-Gallego, P. Ramı́rez-López, M. J. Mancheño, M. A. Sierra and M. R. Torres, Chem.–Eur. J., 2010, 16, 1592; (b) D. Pellico, M. Gómez-Gallego, P. Ramı́rez-López, M. J. Mancheño, M. A. Sierra and M. R. Torres, Chem.–Eur. J., 2009, 15, 6940; (c) M. A. Sierra, D. Pellico, M. Gómez-Gallego, M. J. Mancheño and M. R. Torres, J. Org. Chem., 2006, 71, 8787. 16 The concept of peripheral functionalization was initially introduced by Still and Schreiber: (a) W. C. Still and A. G. Romero, J. Am. Chem. Soc., 1986, 108, 2105; (b) S. L. Schreiber, T. Sammakia, B. Hulin and G. Schulte, J. Am. Chem. Soc., 1986, 108, 2106. 17 (a) F. Yunta, S. Garcı́a-Marco, J. J. Lucena, M. Gómez-Gallego, R. Alcázar and M. A. Sierra, Inorg. Chem., 2003, 42, 5412; (b) M. A. Sierra, M. Gómez-Gallego, R. Alcázar, J. J. Lucena, F. Yunta and S. Garcı́a-Marco, Dalton Trans., 2004, 3741; (c) M. Gómez-Gallego, M. A. Sierra, R. Alcázar, P. Ramı́rez, C. Piñar, M. J. Mancheño, S. Garcı́a- Marco, F. Yunta and J. J. Lucena, J. Agric. Food Chem., 2002, 50, 6395. 18 Compounds 8 are closely related to the macrocyclic bis b-aminoacids prepared by us by periphery functionalization of macrocyclic diimines (see ref. 17c) and also share structural features with the known chelating agent o,o-EDDHA and with the lipophilic prodrug DP-109 (1,2- bis(2-aminophenyloxy)ethane-N,N,N¢,N¢-tetraacetic acid) that shows a great chelating efficacy for Zn(II) and Cu(II) ions and is under trial as a viable candidate for Alzheimer’s disease therapy. See: L. E. Scott and C. Orvig, Chem. Rev., 2009, 109, 4885. 19 (a) M. S. Sigman, P. Vachal and E. N. Jacobsen, Angew. Chem., Int. Ed., 2000, 39, 1279; (b) H. Groger, Chem. Rev., 2003, 103, 2795; (c) M. S. Taylor and E. N. Jacobsen, Angew. Chem., Int. Ed., 2006, 45, 1520. 20 See for example: (a) J. Blacker, L. A. Clutterbuck, M. R. Crampton, C. Grosjean and M. North, Tetrahedron: Asymmetry, 2006, 17, 1449; (b) N. S. Josephson, K. W. Kuntz, M. L. Snapper and A. H. Hoveyda, J. Am. Chem. Soc., 2001, 123, 11594. 21 a-Aminonitriles easily decompose by means of the undesirable retro- Strecker reaction. See: P. Vachal and E. N. Jacobsen, Org. Lett., 2000, 2, 867. 22 Dimeric structures of Cu(II) complexes. From macrocyclic ligands: (a) X-H. Bu, M. Du, L. Zhang, Z-L. Shang, R-H Zhang and M. Shionoya, J. Chem. Soc., Dalton Trans., 2001, 729; (b) D. Kong, J. Mao, A. E. Martell and A. Clearfield, Inorg. Chim. Acta, 2003, 342, 260. Acyclic ligands: ; (c) C.-T. Yang, M. Vetrichelvan, X. Yang, B. Moubaraki, K. S. Murray and J. J. Vittal, Dalton Trans., 2004, 113; (d) S. Reinoso, P. Vitoria, L. San Felices, A. Montero, L. Lezama and J. M. Gutiérrez-Zorrilla, Inorg. Chem., 2007, 46, 1237; (e) A. Erxleben, Inorg. Chim. Acta, 2009, 362, 839; (f) T. Gunnlaugsson, M. Nieuwenhuyzen and C. Nolan, Polyhedron, 2003, 22, 3231; (g) A. S. de Sousa and M. A. Fernandes, Polyhedron, 2002, 21, 1883; (h) P. Gómez-Saiz, R. Gil- Garcı́a, M. A. Maestro, J. L. Pizarro, M. I. Arriortua, L. Lezama, T. Rojo, M. González-Álvarez, J. Borrás and J. Garcı́a-Tojal, J. Inorg. Biochem., 2008, 102, 1910. 23 For N,O coordinated N-branched (N-CH2CH2OH and N- CH2CONH2) Ni(II) macrocyclic complexes, see: (a) K. R. Adam, C. Clarkson, A. J. Leong, L. F. Lindoy, M. McPartlin, H. R. Powell and S. V. Smith, J. Chem. Soc., Dalton Trans., 1994, 2791. For the analogous N,O coordinated non-branched macrocycles, see: (b) K. Henrick, L. F. Lindoy, M. McPartlin, P. A. Tasker and M. P. Wood, J. Am. Chem. Soc., 1984, 106, 1641; (c) L. A. Drummond, K. Henrick, M. J. L Kanagasundaram, L. F. Lindoy, M. McPartlin and P. A. Tasker, Inorg. Chem., 1982, 21, 3923. For non-coordination of the ether oxygen donor atoms in macrocyclic Ni(II) complexes, see for example: (d) N. A. Bailey, D. E. Fenton, S. J. Kitchen, T. H. Lilley, M. G. Williams, P. A. Tasker, A. J. Leong and L. F. Lindoy, J. Chem. Soc., Dalton Trans., 1991, 7627; (e) H. Adams, N. A. Bailey, D. E. Fenton, S. J. Kitchen and P. A. Tasker, J. Chem. Soc., Dalton Trans., 1990, 1111. 24 For N,O coordination in non-branched macrocyclic Cu(II) complexes, see for example: (a) K. R. Adam, G. Anderegg, L. F. Lindoy, H. C. Lip, M. McPartlin, J. H. Rea, R. J. Smith and P. A. Tasker, Inorg. Chem., 1980, 19, 2956. For non-coordination of the ether oxygen donor atoms in Cu(II) complexes, see for example: (b) K. R. Adam, L. F. Lindoy, H. C. Lip, J. H. Rea, B. W. Skehon and A. H. White, J. Chem. Soc., Dalton Trans., 1981, 74. 25 (a) A. Simion, C. Simion, T. Kanda, S. Nagashima, Y. Mitoma, T. Yamada, K. Mimuro and M. Tashiro, J. Chem. Soc., Perkin Trans. 1, 2001, 2071; (b) C. Simion, A. Simion, Y. Mitoma, S. Nagashima, T. Kawaji, I. Hashimoto and M. Tashiro, Heterocycles, 2000, 53, 2459. 26 SADABS: Area-detector absorption correction, Bruker-AXS, Madison, WI, 1996. 27 (a) SHELXTL Package v. 6.10, Bruker-AXS, Madison, WI, 2000; (b) G. Sheldrick, Acta Crystallogr., 2008, A64, 112. This journal is © The Royal Society of Chemistry 2011 Dalton Trans., 2011, 40, 9145–9153 | 9153 D ow nl oa de d by In sti tu to d e M ic ro bi ol og ía B io qu ím ic a on 0 5 Se pt em be r 2 01 1 Pu bl ish ed o n 08 A ug us t 2 01 1 on h ttp :// pu bs .rs c. or g | d oi :1 0. 10 39 /C 1D T1 05 39 F View Online http://dx.doi.org/10.1039/c1dt10539f